nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—Methylprednisolone—psoriatic arthritis	0.136	0.279	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—psoriatic arthritis	0.0883	0.182	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—psoriatic arthritis	0.0872	0.179	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—psoriatic arthritis	0.0823	0.169	CbGbCtD
Dabigatran etexilate—F2—knee—psoriatic arthritis	0.0638	0.536	CbGeAlD
Dabigatran etexilate—ABCB1—Dexamethasone—psoriatic arthritis	0.0514	0.106	CbGbCtD
Dabigatran etexilate—ABCB1—Methotrexate—psoriatic arthritis	0.0413	0.0849	CbGbCtD
Dabigatran etexilate—F2—vertebral column—psoriatic arthritis	0.0364	0.306	CbGeAlD
Dabigatran etexilate—CES2—skin of body—psoriatic arthritis	0.0077	0.0648	CbGeAlD
Dabigatran etexilate—CES2—tendon—psoriatic arthritis	0.00586	0.0493	CbGeAlD
Dabigatran etexilate—NQO2—tendon—psoriatic arthritis	0.00524	0.044	CbGeAlD
Dabigatran etexilate—Ecchymosis—Prednisone—psoriatic arthritis	0.00181	0.00459	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00177	0.00449	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Betamethasone—psoriatic arthritis	0.00171	0.00434	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00171	0.00434	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00167	0.00423	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00167	0.00423	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00162	0.0041	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.0016	0.00406	CcSEcCtD
Dabigatran etexilate—Influenza—Triamcinolone—psoriatic arthritis	0.00159	0.00403	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00156	0.00396	CcSEcCtD
Dabigatran etexilate—Bronchitis—Triamcinolone—psoriatic arthritis	0.00153	0.00388	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00152	0.00385	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Methotrexate—psoriatic arthritis	0.00151	0.00384	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00151	0.00383	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Prednisone—psoriatic arthritis	0.00149	0.00378	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00148	0.00375	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Prednisone—psoriatic arthritis	0.00145	0.00369	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00145	0.00369	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00142	0.00359	CcSEcCtD
Dabigatran etexilate—Infestation—Methylprednisolone—psoriatic arthritis	0.00142	0.00359	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.0014	0.00354	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.0014	0.00354	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisolone—psoriatic arthritis	0.00139	0.00353	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00139	0.00352	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00139	0.00352	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisolone—psoriatic arthritis	0.00138	0.00351	CcSEcCtD
Dabigatran etexilate—Epistaxis—Triamcinolone—psoriatic arthritis	0.00134	0.00339	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00128	0.00325	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00128	0.00324	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00128	0.00324	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00127	0.00323	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00127	0.00322	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00127	0.00322	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00127	0.00322	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00126	0.0032	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00126	0.0032	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00125	0.00316	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00122	0.00308	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00118	0.00299	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00116	0.00294	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Betamethasone—psoriatic arthritis	0.00116	0.00294	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Betamethasone—psoriatic arthritis	0.00116	0.00293	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00116	0.00293	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00115	0.00292	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00115	0.00291	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00115	0.0029	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00112	0.00284	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00111	0.0028	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00111	0.0028	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—psoriatic arthritis	0.0011	0.00279	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisone—psoriatic arthritis	0.0011	0.00278	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisolone—psoriatic arthritis	0.00108	0.00274	CcSEcCtD
Dabigatran etexilate—Back pain—Triamcinolone—psoriatic arthritis	0.00107	0.00272	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00106	0.00268	CcSEcCtD
Dabigatran etexilate—Angiopathy—Betamethasone—psoriatic arthritis	0.00105	0.00266	CcSEcCtD
Dabigatran etexilate—Angiopathy—Dexamethasone—psoriatic arthritis	0.00105	0.00266	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—psoriatic arthritis	0.00104	0.00264	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—psoriatic arthritis	0.00101	0.00257	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—psoriatic arthritis	0.00101	0.00256	CcSEcCtD
Dabigatran etexilate—Angioedema—Methylprednisolone—psoriatic arthritis	0.00101	0.00256	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00101	0.00255	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—psoriatic arthritis	0.00101	0.00255	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—psoriatic arthritis	0.000994	0.00252	CcSEcCtD
Dabigatran etexilate—Syncope—Methylprednisolone—psoriatic arthritis	0.000992	0.00251	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000989	0.00251	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000984	0.00249	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000977	0.00247	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000974	0.00247	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000972	0.00246	CcSEcCtD
Dabigatran etexilate—Shock—Prednisolone—psoriatic arthritis	0.000968	0.00245	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—psoriatic arthritis	0.000967	0.00245	CcSEcCtD
Dabigatran etexilate—Hypertension—Triamcinolone—psoriatic arthritis	0.000957	0.00243	CcSEcCtD
Dabigatran etexilate—Hypertension—Methylprednisolone—psoriatic arthritis	0.000955	0.00242	CcSEcCtD
Dabigatran etexilate—Pneumonia—Methotrexate—psoriatic arthritis	0.000942	0.00239	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000942	0.00239	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methotrexate—psoriatic arthritis	0.000937	0.00237	CcSEcCtD
Dabigatran etexilate—Infestation—Methotrexate—psoriatic arthritis	0.000937	0.00237	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000935	0.00237	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—psoriatic arthritis	0.000919	0.00233	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—psoriatic arthritis	0.000919	0.00233	CcSEcCtD
Dabigatran etexilate—Angiopathy—Prednisone—psoriatic arthritis	0.000913	0.00231	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—psoriatic arthritis	0.000909	0.0023	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000905	0.00229	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000903	0.00229	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—psoriatic arthritis	0.000902	0.00229	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—psoriatic arthritis	0.000902	0.00229	CcSEcCtD
Dabigatran etexilate—Infection—Triamcinolone—psoriatic arthritis	0.000899	0.00228	CcSEcCtD
Dabigatran etexilate—Infection—Methylprednisolone—psoriatic arthritis	0.000897	0.00227	CcSEcCtD
Dabigatran etexilate—Haematuria—Methotrexate—psoriatic arthritis	0.000893	0.00226	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—psoriatic arthritis	0.00089	0.00226	CcSEcCtD
Dabigatran etexilate—Shock—Methylprednisolone—psoriatic arthritis	0.000888	0.00225	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000886	0.00225	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000885	0.00224	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000884	0.00224	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000884	0.00224	CcSEcCtD
Dabigatran etexilate—Epistaxis—Methotrexate—psoriatic arthritis	0.000884	0.00224	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000877	0.00222	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—psoriatic arthritis	0.000876	0.00222	CcSEcCtD
Dabigatran etexilate—Hypertension—Dexamethasone—psoriatic arthritis	0.000869	0.0022	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—psoriatic arthritis	0.000869	0.0022	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methotrexate—psoriatic arthritis	0.000845	0.00214	CcSEcCtD
Dabigatran etexilate—Hypotension—Methylprednisolone—psoriatic arthritis	0.000844	0.00214	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methotrexate—psoriatic arthritis	0.000841	0.00213	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000831	0.0021	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Methotrexate—psoriatic arthritis	0.000824	0.00209	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000824	0.00209	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000823	0.00208	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000821	0.00208	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000821	0.00208	CcSEcCtD
Dabigatran etexilate—Infection—Betamethasone—psoriatic arthritis	0.000816	0.00207	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—psoriatic arthritis	0.000816	0.00207	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—psoriatic arthritis	0.00081	0.00205	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—psoriatic arthritis	0.000808	0.00205	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—psoriatic arthritis	0.000808	0.00205	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000807	0.00204	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000805	0.00204	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000805	0.00204	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000804	0.00204	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000804	0.00204	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—psoriatic arthritis	0.000801	0.00203	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000797	0.00202	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000795	0.00201	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—psoriatic arthritis	0.000786	0.00199	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisolone—psoriatic arthritis	0.000782	0.00198	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000781	0.00198	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—psoriatic arthritis	0.00078	0.00198	CcSEcCtD
Dabigatran etexilate—Fatigue—Methylprednisolone—psoriatic arthritis	0.000778	0.00197	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisone—psoriatic arthritis	0.00077	0.00195	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—psoriatic arthritis	0.000767	0.00194	CcSEcCtD
Dabigatran etexilate—Hypotension—Dexamethasone—psoriatic arthritis	0.000767	0.00194	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methotrexate—psoriatic arthritis	0.000763	0.00193	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00076	0.00192	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000758	0.00192	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisone—psoriatic arthritis	0.000756	0.00192	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000748	0.0019	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000748	0.0019	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—psoriatic arthritis	0.000746	0.00189	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000741	0.00188	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000738	0.00187	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methotrexate—psoriatic arthritis	0.000732	0.00186	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000725	0.00184	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—psoriatic arthritis	0.000723	0.00183	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000723	0.00183	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—psoriatic arthritis	0.000719	0.00182	CcSEcCtD
Dabigatran etexilate—Urticaria—Methylprednisolone—psoriatic arthritis	0.000717	0.00182	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000715	0.00181	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000714	0.00181	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—psoriatic arthritis	0.00071	0.0018	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000709	0.0018	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000709	0.0018	CcSEcCtD
Dabigatran etexilate—Back pain—Methotrexate—psoriatic arthritis	0.000708	0.00179	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—psoriatic arthritis	0.000708	0.00179	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—psoriatic arthritis	0.000708	0.00179	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—psoriatic arthritis	0.000703	0.00178	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—psoriatic arthritis	0.000701	0.00178	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—psoriatic arthritis	0.000694	0.00176	CcSEcCtD
Dabigatran etexilate—Anaemia—Methotrexate—psoriatic arthritis	0.000677	0.00171	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000671	0.0017	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000671	0.0017	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000667	0.00169	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000665	0.00169	CcSEcCtD
Dabigatran etexilate—Urticaria—Dexamethasone—psoriatic arthritis	0.000652	0.00165	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—psoriatic arthritis	0.000652	0.00165	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000651	0.00165	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—psoriatic arthritis	0.000651	0.00165	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—psoriatic arthritis	0.000649	0.00164	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000649	0.00164	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000649	0.00164	CcSEcCtD
Dabigatran etexilate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000648	0.00164	CcSEcCtD
Dabigatran etexilate—Pruritus—Triamcinolone—psoriatic arthritis	0.00064	0.00162	CcSEcCtD
Dabigatran etexilate—Cough—Methotrexate—psoriatic arthritis	0.000639	0.00162	CcSEcCtD
Dabigatran etexilate—Pruritus—Methylprednisolone—psoriatic arthritis	0.000639	0.00162	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Prednisone—psoriatic arthritis	0.000629	0.00159	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methotrexate—psoriatic arthritis	0.000623	0.00158	CcSEcCtD
Dabigatran etexilate—Chest pain—Methotrexate—psoriatic arthritis	0.000623	0.00158	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—psoriatic arthritis	0.00062	0.00157	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—psoriatic arthritis	0.00062	0.00157	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000619	0.00157	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000618	0.00157	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—psoriatic arthritis	0.000616	0.00156	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—psoriatic arthritis	0.000616	0.00156	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—psoriatic arthritis	0.000611	0.00155	CcSEcCtD
Dabigatran etexilate—Dizziness—Triamcinolone—psoriatic arthritis	0.000598	0.00152	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000598	0.00151	CcSEcCtD
Dabigatran etexilate—Dizziness—Methylprednisolone—psoriatic arthritis	0.000597	0.00151	CcSEcCtD
Dabigatran etexilate—Infection—Methotrexate—psoriatic arthritis	0.000594	0.0015	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—psoriatic arthritis	0.000589	0.00149	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—psoriatic arthritis	0.000589	0.00149	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000586	0.00148	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000585	0.00148	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000585	0.00148	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—psoriatic arthritis	0.000584	0.00148	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—psoriatic arthritis	0.000581	0.00147	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—psoriatic arthritis	0.000581	0.00147	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methotrexate—psoriatic arthritis	0.00058	0.00147	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—psoriatic arthritis	0.000575	0.00146	CcSEcCtD
Dabigatran etexilate—Vomiting—Methylprednisolone—psoriatic arthritis	0.000574	0.00145	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—psoriatic arthritis	0.000571	0.00145	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—psoriatic arthritis	0.00057	0.00144	CcSEcCtD
Dabigatran etexilate—Rash—Methylprednisolone—psoriatic arthritis	0.000569	0.00144	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000569	0.00144	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—psoriatic arthritis	0.000568	0.00144	CcSEcCtD
Dabigatran etexilate—Headache—Triamcinolone—psoriatic arthritis	0.000567	0.00144	CcSEcCtD
Dabigatran etexilate—Headache—Methylprednisolone—psoriatic arthritis	0.000566	0.00143	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—psoriatic arthritis	0.000565	0.00143	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000562	0.00142	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000562	0.00142	CcSEcCtD
Dabigatran etexilate—Hypotension—Methotrexate—psoriatic arthritis	0.000558	0.00141	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000544	0.00138	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—psoriatic arthritis	0.000543	0.00138	CcSEcCtD
Dabigatran etexilate—Dizziness—Dexamethasone—psoriatic arthritis	0.000543	0.00138	CcSEcCtD
Dabigatran etexilate—Nausea—Triamcinolone—psoriatic arthritis	0.000537	0.00136	CcSEcCtD
Dabigatran etexilate—Nausea—Methylprednisolone—psoriatic arthritis	0.000536	0.00136	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000533	0.00135	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000527	0.00133	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methotrexate—psoriatic arthritis	0.000526	0.00133	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—psoriatic arthritis	0.000522	0.00132	CcSEcCtD
Dabigatran etexilate—Vomiting—Dexamethasone—psoriatic arthritis	0.000522	0.00132	CcSEcCtD
Dabigatran etexilate—Rash—Dexamethasone—psoriatic arthritis	0.000518	0.00131	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—psoriatic arthritis	0.000518	0.00131	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—psoriatic arthritis	0.000517	0.00131	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000517	0.00131	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000516	0.00131	CcSEcCtD
Dabigatran etexilate—Fatigue—Methotrexate—psoriatic arthritis	0.000515	0.00131	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—psoriatic arthritis	0.000514	0.0013	CcSEcCtD
Dabigatran etexilate—Headache—Betamethasone—psoriatic arthritis	0.000514	0.0013	CcSEcCtD
Dabigatran etexilate—Asthenia—Prednisone—psoriatic arthritis	0.000513	0.0013	CcSEcCtD
Dabigatran etexilate—Pruritus—Prednisone—psoriatic arthritis	0.000506	0.00128	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Prednisone—psoriatic arthritis	0.000489	0.00124	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000489	0.00124	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—psoriatic arthritis	0.000488	0.00124	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—psoriatic arthritis	0.000488	0.00124	CcSEcCtD
Dabigatran etexilate—Urticaria—Methotrexate—psoriatic arthritis	0.000475	0.0012	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisone—psoriatic arthritis	0.000473	0.0012	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000472	0.0012	CcSEcCtD
Dabigatran etexilate—Vomiting—Prednisone—psoriatic arthritis	0.000455	0.00115	CcSEcCtD
Dabigatran etexilate—Rash—Prednisone—psoriatic arthritis	0.000451	0.00114	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—psoriatic arthritis	0.00045	0.00114	CcSEcCtD
Dabigatran etexilate—Headache—Prednisone—psoriatic arthritis	0.000448	0.00113	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00044	0.00112	CcSEcCtD
Dabigatran etexilate—Asthenia—Methotrexate—psoriatic arthritis	0.000429	0.00109	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisone—psoriatic arthritis	0.000425	0.00108	CcSEcCtD
Dabigatran etexilate—Pruritus—Methotrexate—psoriatic arthritis	0.000423	0.00107	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000409	0.00104	CcSEcCtD
Dabigatran etexilate—Dizziness—Methotrexate—psoriatic arthritis	0.000395	0.001	CcSEcCtD
Dabigatran etexilate—Vomiting—Methotrexate—psoriatic arthritis	0.00038	0.000963	CcSEcCtD
Dabigatran etexilate—Rash—Methotrexate—psoriatic arthritis	0.000377	0.000955	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methotrexate—psoriatic arthritis	0.000376	0.000954	CcSEcCtD
Dabigatran etexilate—Headache—Methotrexate—psoriatic arthritis	0.000374	0.000948	CcSEcCtD
Dabigatran etexilate—Nausea—Methotrexate—psoriatic arthritis	0.000355	0.000899	CcSEcCtD
